Pages with the fewest revisions

Showing below up to 50 results in range #151 to #200.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. 22. Nephrosclerosis‏‎ (1 revision)
  2. 33. Intravascular radiologic interventions I. Methods of revascularization (PTA, stent implantation, selective thrombolysis, catheter thrombectomy/embolectomy).‏‎ (1 revision)
  3. Kidney biopsy‏‎ (1 revision)
  4. Chondromalacia patellae‏‎ (1 revision)
  5. B10. Surgical treatment of adrenal tumors‏‎ (1 revision)
  6. 8. Interstitial pulmonary diseases. Pulmonary fibrosis. Silicosis. Emphysema.‏‎ (1 revision)
  7. 13. Molecular mechanisms of blood pressure regulation‏‎ (1 revision)
  8. 5. Lipoproteins‏‎ (1 revision)
  9. 34. Lysosomes, peroxisomes‏‎ (1 revision)
  10. Legg-Calve-Perthes disease‏‎ (1 revision)
  11. B13. Treatment of infertility (ovulation induction therapy, AIH, IVF, ICSI)‏‎ (1 revision)
  12. 83. Harmful effects of drugs‏‎ (1 revision)
  13. 50. Hypo-, hyper- and dys-proteinemia‏‎ (1 revision)
  14. 35. Meningioma‏‎ (1 revision)
  15. Lower urinary tract symptoms‏‎ (1 revision)
  16. Congenital anomalies of the kidney‏‎ (1 revision)
  17. B17. Natural history and complications of gastro-duodenal ulcers‏‎ (1 revision)
  18. 9. Child and adolescent health‏‎ (1 revision)
  19. 24. Urologic and male genital cancers‏‎ (1 revision)
  20. 15. Cochlear implantation‏‎ (1 revision)
  21. 36. Radiologic interventions in tumor treatment (Tumor ablation techniques. Selective cytostatic treatment, chemoembolization).‏‎ (1 revision)
  22. Targeted therapy‏‎ (1 revision)
  23. Cricothyrotomy‏‎ (1 revision)
  24. B2. Femoral neck fractures and their complications. Femoral head fractures‏‎ (1 revision)
  25. 9B. Thrombosis of the intracranial sinuses‏‎ (1 revision)
  26. 54. Aplastic anemia and anemias of complex etiology in disease states‏‎ (1 revision)
  27. 37. Medulloblastoma‏‎ (1 revision)
  28. Diffuse large B-cell lymphoma‏‎ (1 revision)
  29. A11. Scleroderma and its variants‏‎ (1 revision)
  30. 26. Laboratory monitoring the therapy of myocardial infarction. Laboratory approaches in chronic heart failure (BNP, proBNP, electrolytes).‏‎ (1 revision)
  31. 56. Acute osteomyelitis‏‎ (1 revision)
  32. 38. Senescence‏‎ (1 revision)
  33. Nephropathy associated with vasculitis‏‎ (1 revision)
  34. B27. Urinary obstruction and stasis: Differential diagnosis and management‏‎ (1 revision)
  35. A14. Hormonal contraception; indications, contraindications, positive effects and potential complications‏‎ (1 revision)
  36. 27. Clinicopathological classification of hypertension and complications‏‎ (1 revision)
  37. 17. Development of the brainstem and the cerebellum‏‎ (1 revision)
  38. 58. Cysts and tumours of the ovaries (surface epithelial, germ cell, sex cordstromal tumours, tumours, metastases)‏‎ (1 revision)
  39. 4. Causes and forms of heart failure‏‎ (1 revision)
  40. Uric acid‏‎ (1 revision)
  41. Erectile dysfunction‏‎ (1 revision)
  42. B30. Pyelitis in pregnancy‏‎ (1 revision)
  43. A19. Methods of local anesthesia (conduction anesthesia, regional anesthesia)‏‎ (1 revision)
  44. 18. Adrenergic receptor antagonists (alpha blockers and beta blockers)‏‎ (1 revision)
  45. 4. Regulation of glycogen synthesis and degradation‏‎ (1 revision)
  46. Osteosarcoma‏‎ (1 revision)
  47. Folliculitis‏‎ (1 revision)
  48. B4. Fetal lie. Assessing fetal lie‏‎ (1 revision)
  49. 6. Pulmonary embolism. Diagnosis and diagnostic difficulties.‏‎ (1 revision)
  50. 18. Pathogenesis of coronary insufficiency. Risk factors‏‎ (1 revision)

View ( | ) (20 | 50 | 100 | 250 | 500)